Answer
Anzupgo (delgocitinib) cream is licensed to treat moderate to severe chronic hand eczema in adults for whom topical corticosteroids are inadequate or inappropriate.
Sources for this answer
- Anzupgo 20 mg/g creamLeo Laboratories Limited · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked